Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a new deployed version of the page metadata. The change appears to be administrative and does not alter study details or user-facing functionality.SummaryDifference0.0%

- Check18 days agoChange DetectedA new citation for Schattenberg JM et al. on qFibrosis regression with resmetirom was added to the Publications section, and the previous online-ahead-of-print citation was removed.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page shows a new revision label, v3.6.4, indicating a version update of the page. This update does not modify the study details or the publicly displayed endpoints.SummaryDifference0.0%

- Check33 days agoChange DetectedSteatotic Liver Disease has been added to the glossary, and Fatty Liver Disease has been removed. This reflects a terminology update in how liver conditions are described on the page.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing v3.6.2, indicating a newer version of the site's software. This update appears to be a backend/platform revision rather than a change to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page shows a new revision tag v3.6.2, replacing the previous v3.6.0. This indicates a small update to page metadata.SummaryDifference0.0%

Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.